Literature DB >> 15735802

Performance of magnetic resonance angiography in suspected acute pulmonary embolism.

Alain Blum1, Abdelouahab Bellou, Francis Guillemin, Philippe Douek, Marie-Claude Laprévote-Heully, Denis Wahl.   

Abstract

Pulmonary embolism (PE) is a common and potentially fatal disorder. Non-specific findings make the clinical diagnosis of PE difficult. To assess the diagnostic value and inter-observer agreement of magnetic resonance angiography (MRA) in a cohort of patients with suspected PE, we conducted a prospective clinical study. MRA was compared for sensitivity and specificity to a diagnostic strategy including clinical probability, D-dimer testing, spiral CT, ultrasound leg compression and pulmonary angiography. A total of 89 patients with clinically suspected PE were included: the clinical probability of PE was intermediate or high in 78, and low in the remaining 11. All patients underwent monoor multi-slice spiral CT and MRA with gadolinium injection (both within 24 hours of entry to the study). Anticoagulation was withheld in patients concerned about the strategy. All subjects were followed up for 3 months. MRA was read independently by two experienced teams of radiologists: one local and one from another university centre. Spiral CT was positive in 62 of 63 cases of confirmed PE. No patient with negative CT findings was positive ultrasonographically. Only one patient with a negative CT (and negative ultrasound) had a recurrent thromboembolic event. The first team diagnosed PE with MRA in 47 cases, with a sensitivity of 71% and a specificity of 92%; the second team obtained the diagnosis in 23 cases, with a sensitivity of 31% and a specificity of 85%. Inter-observer agreement between MRA reading was low: Kappa = 0.16 (-0.01 to 0.33); p = 0.07. In conclusion, compared with a non-invasive strategy based on spiral CT, the diagnostic value of MRA is limited by poor inter-observer agreement.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15735802     DOI: 10.1160/TH04-08-0495

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  9 in total

Review 1.  [MRI of pulmonary embolism].

Authors:  C Fink; S Thieme; S Ley; D Clevert; M F Reiser; H-U Kauczor; S O Schoenberg
Journal:  Radiologe       Date:  2007-08       Impact factor: 0.635

2.  Noninvasive label-free detection of circulating white and red blood clots in deep vessels with a focused photoacoustic probe.

Authors:  Mazen A Juratli; Yulian A Menyaev; Mustafa Sarimollaoglu; Alexander V Melerzanov; Dmitry A Nedosekin; William C Culp; James Y Suen; Ekaterina I Galanzha; Vladimir P Zharov
Journal:  Biomed Opt Express       Date:  2018-10-23       Impact factor: 3.732

3.  Gadolinium-enhanced magnetic resonance angiography for pulmonary embolism: a multicenter prospective study (PIOPED III).

Authors:  Paul D Stein; Thomas L Chenevert; Sarah E Fowler; Lawrence R Goodman; Alexander Gottschalk; Charles A Hales; Russell D Hull; Kathleen A Jablonski; Kenneth V Leeper; David P Naidich; Daniel J Sak; H Dirk Sostman; Victor F Tapson; John G Weg; Pamela K Woodard
Journal:  Ann Intern Med       Date:  2010-04-06       Impact factor: 25.391

4.  Factors in the technical quality of gadolinium enhanced magnetic resonance angiography for pulmonary embolism in PIOPED III.

Authors:  H Dirk Sostman; Kathleen A Jablonski; Pamela K Woodard; Paul D Stein; David P Naidich; Thomas L Chenevert; John G Weg; Charles A Hales; Russell D Hull; Lawrence R Goodman; Victor F Tapson
Journal:  Int J Cardiovasc Imaging       Date:  2011-02-24       Impact factor: 2.357

5.  Signal quality of single dose gadobenate dimeglumine pulmonary MRA examinations exceeds quality of MRA performed with double dose gadopentetate dimeglumine.

Authors:  Pamela K Woodard; Thomas L Chenevert; H Dirk Sostman; Kathleen A Jablonski; Paul D Stein; Lawrence R Goodman; Frank J Londy; Vamsidhar Narra; Charles A Hales; Russell D Hull; Victor F Tapson; John G Weg
Journal:  Int J Cardiovasc Imaging       Date:  2011-02-20       Impact factor: 2.357

6.  Effectiveness of MR angiography for the primary diagnosis of acute pulmonary embolism: clinical outcomes at 3 months and 1 year.

Authors:  Mark L Schiebler; Scott K Nagle; Christopher J François; Michael D Repplinger; Azita G Hamedani; Karl K Vigen; Rajkumar Yarlagadda; Thomas M Grist; Scott B Reeder
Journal:  J Magn Reson Imaging       Date:  2013-04-01       Impact factor: 4.813

Review 7.  Methods of Prospective Investigation of Pulmonary Embolism Diagnosis III (PIOPED III).

Authors:  Paul D Stein; Alexander Gottschalk; H Dirk Sostman; Thomas L Chenevert; Sarah E Fowler; Lawrence R Goodman; Charles A Hales; Russell D Hull; Emanuel Kanal; Kenneth V Leeper; David P Nadich; Daniel J Sak; Victor F Tapson; Thomas W Wakefield; John G Weg; Pamela K Woodard
Journal:  Semin Nucl Med       Date:  2008-11       Impact factor: 4.446

Review 8.  Prognostic stratification of acute pulmonary embolism: focus on clinical aspects, imaging, and biomarkers.

Authors:  Luca Masotti; Marc Righini; Nicolas Vuilleumier; Fabio Antonelli; Giancarlo Landini; Roberto Cappelli; Patrick Ray
Journal:  Vasc Health Risk Manag       Date:  2009-07-14

Review 9.  Magnetic resonance imaging of acute pulmonary embolism.

Authors:  Christian Fink; Sebastian Ley; Stefan O Schoenberg; Maximilian F Reiser; H U Kauczor
Journal:  Eur Radiol       Date:  2007-05-08       Impact factor: 7.034

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.